Mediterr J Rheumatol 2018;29(3):173-7
Extensive phenotyping of vascular damage in non-infectious primary vasculitides with the use of non-invasive vascular biomarkers: prevalence, pathogenesis and response to treatment
Authors Information

Department of Pathophysiology, “Laiko” Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece

  1. Elefante E, Tripoli A, Ferro F, Baldini C: One year in review: systemic vasculitis. Clin Exp Rheumatol 2016;34(Suppl.97):S1-S6. [PMID: 27214397]
  2. Nelson S S, Pande S, Kushwah A P S. A study of atherosclerosis in Systemic vasculitis. Int J Sci Stud 2014;2:25-9.
  3. Eleftheriadis E, Eleftheriadis N. Coronary Artery Disease and Systemic Vasculitis: Case report and Review. Coronary Artery Diseases, edited by Dr IIIya Chaikovsky. INTECH 2012;13:281-300. [http://doi.org/10.5772/30544]
  4. Adebajo A, Dickson D J. Collected reports on the Rheumatic Diseases 2005 series 4 (revised) Primary Systemic Vasculitis. Arthritis Research Campaign (arc) 2005;70-1.
  5. Savage C O, Harper L, Adu D. Primary systemic vasculitis. Lancet 1997;349:553-8. [PMID: 9048802]
  6. Kernani T, Warrington K, Amin S. Malignancy risk in vasculitis. Ther Adv Musculoskel Dis 2011;3(1):55-63. [https://doi.org/10.1177/1759720X10387460] [PMID: 22870466]
  7. Hong J, Marson D, Shirai T, Weyand C. Accelerated atherosclerosis in patients with chronic inflammatory rheumatologic conditions. Int J Clin Rheumatol 2015;10(5):365-81. [PMID: 27042216]
  8. Shirwany N A, Zou M-H. Arterial stiffness: a brief review. Acta Pharmacol Sin 2010;31:1267-76. [http://doi.org/10.1038/aps.2010.123] [PMID: 20802505]
  9. Argyropoulou O D, Protogerou A D, Sfikakis P P. Accelerated atheromatosis and arteriosclerosis in primary systemic vasculitides: current evidence and future perspectives. Curr Opin Rheumatol 2018;30(1):36-43. [https://doi.org/10.1097/BOR.0000000000000453] [PMID: 29040156]